The Patent Finder

Cumbre IP Ventures, L.P.

Also on record
Records under this name other than patents Cumbre IP Ventures, L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cumbre IP Ventures, L.P.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,678,791Nitroheteroaryl-containing rifamycin derivatives
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,884,099Quinolone carboxylic acid-substituted rifamycin derivatives
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,250,413C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
Formerly held
Term ended
Term ended Oct 18, 2025 · USPTO record
Term endedTerm ended Oct 18, 2025USPTO record
US 7,226,931(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions
Formerly held
Term ended
Term ended Sep 25, 2025 · USPTO record
Term endedTerm ended Sep 25, 2025USPTO record
US 7,229,996Rifamycin derivatives
Formerly held
Term ended
Term ended Sep 25, 2025 · USPTO record
Term endedTerm ended Sep 25, 2025USPTO record
US 7,247,634Rifamycin derivatives effective against drug-resistant microbes
Formerly held
Term ended
Term ended Aug 28, 2025 · USPTO record
Term endedTerm ended Aug 28, 2025USPTO record
US 7,238,694Rifamycin imino derivatives effective against drug-resistant microbes
Formerly held
Term ended
Term ended Aug 23, 2025 · USPTO record
Term endedTerm ended Aug 23, 2025USPTO record
US 7,202,246Spiro-rifamycin derivatives targeting RNA polymerase
Formerly held
Term ended
Term ended Jun 8, 2025 · USPTO record
Term endedTerm ended Jun 8, 2025USPTO record
US 7,265,107Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
Formerly held
Lapsed on the fee record
Ended Sep 4, 2019 · USPTO record
Lapsed on the fee recordEnded Sep 4, 2019USPTO record
US 7,256,187Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
Formerly held
Lapsed on the fee record
Ended Aug 14, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 14, 2019USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited